INTEGRATED BIOPHARMA INC (INBP:OTCMKTS)

$0.1889 0.0082 (4.5379%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 59

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) News Sources

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025

23-09-2025

yahoo.com

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025

10-11-2025

yahoo.com

Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025

11-02-2026

yahoo.com

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026

08-05-2026

yahoo.com

INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) Sentiment Trend

0 25 50 75 100 58 59 59 60 23-09-2025 10-11-2025 11-02-2026 08-05-2026 #1 #2 #3 #4 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) FAQs

toggle

What is the current price of INTEGRATED BIOPHARMA INC (INBP:OTCMKTS)?

The current price of INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) is $0.1889.


toggle

INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) absolute price change since previous trading day?

The absolute price change of INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) since the previous trading day is $0.0082.


toggle

INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) percentage price change since previous trading day?

The percentage price change of INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) since the previous trading day is 4.5379%.


toggle

What is the most recent average sentiment score for INTEGRATED BIOPHARMA INC (INBP:OTCMKTS)?

The most recent average sentiment score for INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) is 59 out of 100.


toggle

What is the most recent average sentiment for INTEGRATED BIOPHARMA INC (INBP:OTCMKTS)?

The most recent sentiment for INTEGRATED BIOPHARMA INC (INBP:OTCMKTS) is .


SEC-8K** Filing Available For INTEGRATED BIOPHARMA INC (INBP:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.